(-0.12%) 5 140.75 points
(-0.11%) 38 517 points
(-0.04%) 17 897 points
(-0.33%) $82.36
(1.67%) $2.06
(-0.89%) $2 336.80
(-1.99%) $27.11
(-0.56%) $956.10
(0.22%) $0.934
(0.45%) $11.03
(0.20%) $0.798
(-0.11%) $93.20
@ $5.47
发出时间: 15 Feb 2024 @ 03:51
回报率: -29.43%
上一信号: Feb 15 - 01:36
上一信号:
回报率: 1.86 %
Live Chart Being Loaded With Signals
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa...
Stats | |
---|---|
今日成交量 | 62 832.00 |
平均成交量 | 180 475 |
市值 | 190.61M |
EPS | $0 ( 2024-03-04 ) |
下一个收益日期 | ( $-0.300 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.70 |
ATR14 | $0.00800 (0.21%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Ek John Frederick | Sell | 14 272 | Common Stock |
2024-03-23 | Pla Frederic | Sell | 2 006 | Common Stock |
2024-03-23 | Ramachandran Niro Ph.d | Sell | 2 006 | Common Stock |
2024-03-23 | Mckelligon Brian | Sell | 7 135 | Common Stock |
2024-03-20 | Mckelligon Brian | Sell | 7 500 | Employee Stock Option (Right to Buy) |
INSIDER POWER |
---|
67.45 |
Last 99 transactions |
Buy: 5 199 597 | Sell: 937 556 |
音量 相关性
Akoya Biosciences, Inc. 相关性 - 货币/商品
Akoya Biosciences, Inc. 财务报表
Annual | 2023 |
营收: | $96.63M |
毛利润: | $48.24M (49.92 %) |
EPS: | $-1.430 |
FY | 2023 |
营收: | $96.63M |
毛利润: | $48.24M (49.92 %) |
EPS: | $-1.430 |
FY | 2022 |
营收: | $74.86M |
毛利润: | $43.39M (57.96 %) |
EPS: | $-1.870 |
FY | 2021 |
营收: | $54.92M |
毛利润: | $13.52M (24.62 %) |
EPS: | $-1.485 |
Financial Reports:
No articles found.
Akoya Biosciences, Inc.
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。